Tg Therapeutics (TGTX) Debt Ratio (2010 - 2026)

Tg Therapeutics' Debt Ratio history runs 15 years deep, the most recent figure standing at 0.49 for Q1 2026.

• On a quarterly basis, Debt Ratio rose 30.78% year-over-year to 0.49 in Q1 2026; TTM through Mar 2026 was 0.49, a 30.78% increase from a year earlier, with the FY2025 full-year figure at 0.23, down 45.4% from the prior year.
• Debt Ratio grew to 0.49 in Q1 2026 per TGTX's latest filing, from 0.23 in the prior quarter.
• Across five years, Debt Ratio topped out at 0.49 in Q1 2023 and bottomed at 0.22 in Q1 2022.
• The 5-year median for Debt Ratio is 0.33 (2022), against an average of 0.34.
• Across the five-year window, Debt Ratio surged 735.99% in 2022 and slumped 45.4% in 2025, its largest moves.
• Year by year, Debt Ratio stood at 0.37 in 2022, then declined by 17.34% to 0.3 in 2023, then soared by 39.29% to 0.42 in 2024, then slumped by 45.4% to 0.23 in 2025, then soared by 110.96% to 0.49 in 2026.
• Per Business Quant, the three latest TGTX Debt Ratio figures stand at 0.49 (Q1 2026), 0.23 (Q4 2025), and 0.24 (Q3 2025).